Surgery

FDA predicts opioid stacking may occur because of the acute pain treatment.

New cohort analysis shows patients with ulcerative colitis or Crohn's disease who have received invasive care may be affected long-term.

Low annual donor use and high mortality rates could be correlatively improved with greater embrace of opportunities.

The chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic.

Hinge Health’s Digital Musculoskeletal Clinic aims preventing injuries, as well as post-surgery rehabilitation.

The indication limits the new opioid to clinical setting use—no take-home prescriptions.

A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.

Patients face higher mortality risk if they are readmitted to a different hospital following emergency general surgery.

The first prospective safety trial using oral factor Xa inhibitor in patients undergoing laparotomy shows women preferred and adhered to the drug.

Investigators explain how telemicrosurgery can be performed over a 5G network.

No skin preparation solution is more beneficial or advantageous than others in reducing infection rates.

The iCoagLab test reports several coagulation metrics within minutes, whereas traditionally it can take several hours for coagulation defects to be detected.

Heron Therapeutics is expected to meet with the FDA and resubmit an NDA for the post-operative opioid alternative.

A new randomized trial suggests oral apixaban may be as effective as enoxaparin for thromboprophylaxis following surgery for gynecologic cancer.

It is important to evaluate opioid use among patients before surgery to modify patient-level risk factors.

New research from Penn Medicine indicates 9.6% of heart surgery patients develop persistent opioid use post-procedure.

Gauging patient wellbeing prior to intravitreal injections may help inform clinicians as to who may fare worse with the treatment.

Sleeve gastrectomy is associated with less fracture risk than Roux-en-Y gastric bypass.

Historically, representation of women and minority populations is low in surgical specialties.

Medications can help, especially in situations where weight gain can occur at a rapid rate.

An analysis of the TWILIGHT trial presented at SCAI examines SYNERGY BP-EES in a high-risk patient population.

Patients with obesity can be referred to an established weight loss program before surgery to reduce the risk of mortality.

New research has found use of medication alone was noninferior to using medication and graduated compression socks for preventing VTE following non-emergency surgery.

Use of the checklists is associated with a reduction in the rate of complications, reoperations, and readmissions.

New research suggests a residual shunt following PFO closure puts patients at a much greater risk of recurrent stroke or TIA.